10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 21, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 9:00 a.m. Pacific Time.
Related news for (TXG)
- 24/7 Market News Snapshot 20 October, 2025 – 10x Genomics, Inc. Class A Common Stock (NASDAQ:TXG)
- 10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
- Addentax Group Corp. Announces Strategic Cooperation Discussions with KINGS UNITED to Advance Web3.0 and RWA Initiatives
- 10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
- Breaking News: MoBot’s Latest Update as of 09/22/25 03:00 PM
